Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
American Journal of Obstetrics and Gynecology|May 2, 2006
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomasAlessandro D Santin, Eleftherios P Diamandis, Stefania Bellone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2025
Preclinical activity of sacituzumab govitecan in TROP2-positive low-grade serous ovarian cancer patient-derived xenograft modelsVictoria M Ettorre, Cem Demirkiran, Stefania Bellone, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancerAlessandro D Santin, Mepur H Ravindranath, Stefania Bellone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2016
Improved i.p. drug delivery with bioadhesive nanoparticlesYang Deng, Fan Yang, Emiliano Cocco, et al.
Journal of Virology|December 7, 2007
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trialAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Gynecologic Oncology|October 27, 2005
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalitiesAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Gynecologic Oncology|April 2, 2011
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.
Gynecologic Oncology|June 2, 2007
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic diseaseStefania Bellone, Gianluca Frera, Gianpiero Landolfi, et al.
Breast Cancer Research and Treatment|September 25, 2003
Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cellsRena Kass, Stefania Bellone, Michela Palmieri, et al.
Cancer|February 28, 2007
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)Alessandro D Santin, Stefania Bellone, Moira Marizzoni, et al.
Pageof 17